Analyst stock forecast
AbbVie Forecast: $278.61 Analyst Target
Direct answer
AbbVie's average price target is $278.61.
The target implies +5.6% from the recorded current price, and the consensus rating is Buy.
The low target implies -24.2%, the high target implies +24.3%, and the range spans 48.5% of the current price.
Forecast evidence checked September 18, 2026.
Get free AbbVie email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $263.87
- Average price target
- $278.61
- High price target
- $328.00
- Low price target
- $200.00
- Low target gap
- -24.2%
- Target upside
- +5.6%
- High target gap
- +24.3%
- Target range width
- 48.5%
- Consensus rating
- Buy
- Analysts
- 28
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is AbbVie's average price target?
AbbVie's verified average price target is $278.61. The target range is $200.00 to $328.00.
How far are AbbVie's low and high targets from the recorded price?
The low target implies -24.2%, while the high target implies +24.3%.
How many analysts are included in AbbVie's consensus?
The verified consensus includes 28 analysts.
How is AbbVie's target upside or downside calculated?
The average target of $278.61 is divided by the recorded price of $263.87, then one is subtracted to produce +5.6%. This does not guarantee a future return.
When was AbbVie's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.